Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

National Vaccine Compensation Program

Executive Summary

The Administrative Conference of the U.S. votes unanimously at its June 14 plenary session to accept its Committee on Governmental Processes' final draft recommendations for improving the National Vaccine Compensation Program. The nine draft recommendations include suggestions that the NVCP be better publicized, that it be given a larger staff and more time to handle its current case load, and that guidelines be established to clarify amounts of compensation. The Conference also agrees that a supplemental report addressing new areas of concern (i.e. the excise tax on vaccines, attorney fees) be prepared for the Conference's next plenary session in December.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS019334

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel